Cargando…
Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome
Individual responses to growth hormone (GH) treatment are variable. Short-term generation of insulin-like growth factor-I (IGF-I) is recognized as a potential marker of sensitivity to GH treatment. This prospective, phase IV study used an integrated genomic analysis to identify markers associated wi...
Autores principales: | Stevens, A, Clayton, P, Tatò, L, Yoo, H W, Rodriguez-Arnao, M D, Skorodok, J, Ambler, G R, Zignani, M, Zieschang, J, Della Corte, G, Destenaves, B, Champigneulle, A, Raelson, J, Chatelain, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959225/ https://www.ncbi.nlm.nih.gov/pubmed/23567489 http://dx.doi.org/10.1038/tpj.2013.14 |
Ejemplares similares
-
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome
por: Clayton, P, et al.
Publicado: (2013) -
GH deficiency status combined with GH receptor polymorphism affects response to GH in children
por: Valsesia, Armand, et al.
Publicado: (2015) -
GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021) -
Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study
por: Stevens, Adam, et al.
Publicado: (2016) -
Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021)